Chemo's hidden toll on blood vessels revealed
NCT ID NCT04042298
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study measured blood flow in the skin of 62 people, including cancer patients who received 5-FU chemotherapy, those on other treatments, cancer survivors, and healthy controls. Researchers used a non-invasive laser sensor to see how small blood vessels responded to substances that widen or narrow them. The goal was to understand why 5-FU can cause heart problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help explain how 5-FU chemotherapy affects blood vessels, potentially leading to better monitoring or prevention of heart-related side effects.
- What could go wrong
- This is a small, completed observational study that only measures blood flow at one time point. It does not test any treatment, so it cannot directly improve patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 5-FLUOROURACIL TOXICITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lafene Health Center
Manhattan, Kansas, 66502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Can we predict chemo brain before it happens?
- Radiation may let breast cancer patients keep their nipple